Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Return on Sales (2019 - 2025)

Pulmonx (LUNG) has disclosed Return on Sales for 7 consecutive years, with 0.65% as the latest value for Q3 2025.

  • Quarterly Return on Sales rose 5.0% to 0.65% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.62% through Sep 2025, up 10.0% year-over-year, with the annual reading at 0.67% for FY2024, 21.0% up from the prior year.
  • Return on Sales for Q3 2025 was 0.65% at Pulmonx, down from 0.64% in the prior quarter.
  • The five-year high for Return on Sales was 0.55% in Q4 2024, with the low at 1.47% in Q1 2022.
  • Average Return on Sales over 5 years is 0.89%, with a median of 0.84% recorded in 2023.
  • Peak annual rise in Return on Sales hit 219bps in 2021, while the deepest fall reached -52bps in 2021.
  • Over 5 years, Return on Sales stood at 0.95% in 2021, then increased by 2bps to 0.93% in 2022, then grew by 22bps to 0.72% in 2023, then increased by 23bps to 0.55% in 2024, then fell by -17bps to 0.65% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.65%, 0.64%, and 0.64% for Q3 2025, Q2 2025, and Q1 2025 respectively.